Jaime Rodriguez‐Canales

<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma

Ferdinandos Skoulidis, Michael E. Goldberg, Danielle Greenawalt et al. · Cancer Discovery · 2018 · 1.6K citations · Full text

Medicine, Oncology, Pharmacology +16

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial

Hussein A. Tawbi, Melissa Burgess, Vanessa Bolejack et al. · The Lancet Oncology · 2017 · 1.4K citations · Full text

Medicine, Oncology, Pharmacology +13

Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma

Frederick F. Lang, Charles A. Conrad, Candelaria Gomez‐Manzano et al. · Journal of Clinical Oncology · 2018 · 708 citations

Medicine, Oncology, Pharmacology +17

Gene Expression Profiles in Paraffin-Embedded Core Biopsy Tissue Predict Response to Chemotherapy in Women With Locally Advanced Breast Cancer

Luca Gianni, Milvia Zambetti, Kim Clark et al. · Journal of Clinical Oncology · 2005 · 620 citations

Medicine, Molecular Biology, Oncology +17

A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition

Milena Perez Mak, Pan Tong, Lixia Diao et al. · Clinical Cancer Research · 2015 · 581 citations · Full text

Medicine, Cancer Biology, Oncology +17